Report cover image

Global Opioid Narcotics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 196 Pages
SKU # APRC20277571

Description

Summary

According to APO Research, The global Opioid Narcotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Opioid Narcotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Opioid Narcotics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Narcotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Opioid Narcotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Narcotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Narcotics sales, projected growth trends, production technology, application and end-user industry.

Opioid Narcotics Segment by Company

Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type

Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application

Hospital
Clinic
Other
Opioid Narcotics Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Narcotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Opioid Narcotics Market Size, 2020 VS 2024 VS 2031
1.3 Global Opioid Narcotics Market Size Estimates and Forecasts (2020-2031)
1.4 Global Opioid Narcotics Sales Estimates and Forecasts (2020-2031)
1.5 Global Opioid Narcotics Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Opioid Narcotics Market Dynamics
2.1 Opioid Narcotics Industry Trends
2.2 Opioid Narcotics Industry Drivers
2.3 Opioid Narcotics Industry Opportunities and Challenges
2.4 Opioid Narcotics Industry Restraints
3 Opioid Narcotics Market by Manufacturers
3.1 Global Opioid Narcotics Revenue by Manufacturers (2020-2025)
3.2 Global Opioid Narcotics Sales by Manufacturers (2020-2025)
3.3 Global Opioid Narcotics Average Sales Price by Manufacturers (2020-2025)
3.4 Global Opioid Narcotics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Opioid Narcotics Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Opioid Narcotics Manufacturers, Product Type & Application
3.7 Global Opioid Narcotics Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Opioid Narcotics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Opioid Narcotics Players Market Share by Revenue in 2024
3.8.3 2024 Opioid Narcotics Tier 1, Tier 2, and Tier 3
4 Opioid Narcotics Market by Type
4.1 Opioid Narcotics Type Introduction
4.1.1 Fentanyl
4.1.2 Remifentanil
4.1.3 Sufentanil
4.2 Global Opioid Narcotics Sales by Type
4.2.1 Global Opioid Narcotics Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Opioid Narcotics Sales by Type (2020-2031)
4.2.3 Global Opioid Narcotics Sales Market Share by Type (2020-2031)
4.3 Global Opioid Narcotics Revenue by Type
4.3.1 Global Opioid Narcotics Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Opioid Narcotics Revenue by Type (2020-2031)
4.3.3 Global Opioid Narcotics Revenue Market Share by Type (2020-2031)
5 Opioid Narcotics Market by Application
5.1 Opioid Narcotics Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Opioid Narcotics Sales by Application
5.2.1 Global Opioid Narcotics Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Opioid Narcotics Sales by Application (2020-2031)
5.2.3 Global Opioid Narcotics Sales Market Share by Application (2020-2031)
5.3 Global Opioid Narcotics Revenue by Application
5.3.1 Global Opioid Narcotics Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Opioid Narcotics Revenue by Application (2020-2031)
5.3.3 Global Opioid Narcotics Revenue Market Share by Application (2020-2031)
6 Global Opioid Narcotics Sales by Region
6.1 Global Opioid Narcotics Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Opioid Narcotics Sales by Region (2020-2031)
6.2.1 Global Opioid Narcotics Sales by Region (2020-2025)
6.2.2 Global Opioid Narcotics Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Opioid Narcotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Opioid Narcotics Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Opioid Narcotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Opioid Narcotics Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Opioid Narcotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Opioid Narcotics Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Opioid Narcotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Opioid Narcotics Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Opioid Narcotics Revenue by Region
7.1 Global Opioid Narcotics Revenue by Region
7.1.1 Global Opioid Narcotics Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Opioid Narcotics Revenue by Region (2020-2025)
7.1.3 Global Opioid Narcotics Revenue by Region (2026-2031)
7.1.4 Global Opioid Narcotics Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Opioid Narcotics Revenue (2020-2031)
7.2.2 North America Opioid Narcotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Opioid Narcotics Revenue (2020-2031)
7.3.2 Europe Opioid Narcotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Opioid Narcotics Revenue (2020-2031)
7.4.2 Asia-Pacific Opioid Narcotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Opioid Narcotics Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Opioid Narcotics Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Yichang Renfu Pharmaceutical Co., Ltd.
8.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Comapny Information
8.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
8.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
8.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
8.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
8.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Comapny Information
8.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
8.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
8.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
8.3 Henan Lingrui Pharmaceutical Co., Ltd.
8.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Comapny Information
8.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
8.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
8.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
8.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
8.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Comapny Information
8.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
8.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
8.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
8.5 Changzhou Siyao Pharmaceutical Co., Ltd.
8.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Comapny Information
8.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
8.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
8.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
8.6 Reig Jofre
8.6.1 Reig Jofre Comapny Information
8.6.2 Reig Jofre Business Overview
8.6.3 Reig Jofre Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Reig Jofre Opioid Narcotics Product Portfolio
8.6.5 Reig Jofre Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Pfizer Opioid Narcotics Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 GSK
8.8.1 GSK Comapny Information
8.8.2 GSK Business Overview
8.8.3 GSK Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 GSK Opioid Narcotics Product Portfolio
8.8.5 GSK Recent Developments
8.9 Fresenius Kabi
8.9.1 Fresenius Kabi Comapny Information
8.9.2 Fresenius Kabi Business Overview
8.9.3 Fresenius Kabi Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
8.9.5 Fresenius Kabi Recent Developments
8.10 Daiichi Sankyo
8.10.1 Daiichi Sankyo Comapny Information
8.10.2 Daiichi Sankyo Business Overview
8.10.3 Daiichi Sankyo Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
8.10.5 Daiichi Sankyo Recent Developments
8.11 AcelRx Pharmaceuticals, Inc
8.11.1 AcelRx Pharmaceuticals, Inc Comapny Information
8.11.2 AcelRx Pharmaceuticals, Inc Business Overview
8.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
8.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
8.12 Abbott
8.12.1 Abbott Comapny Information
8.12.2 Abbott Business Overview
8.12.3 Abbott Opioid Narcotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Abbott Opioid Narcotics Product Portfolio
8.12.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Opioid Narcotics Value Chain Analysis
9.1.1 Opioid Narcotics Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Opioid Narcotics Production Mode & Process
9.2 Opioid Narcotics Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Opioid Narcotics Distributors
9.2.3 Opioid Narcotics Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.